Xeris Pharmaceuticals Competitors and Similar CompaniesClear all

Xeris Pharmaceuticals's competitors and similar companies include Aurobindo Pharma, USV, Libbs Farmaceutica and Servier.

	Xeris Pharmaceuticals Xeris Pharmaceuticals is a specialty company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.	Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.	USV USV is a pharmaceutical and biotechnology company.	Libbs Farmaceutica Libbs Farmaceutica is a pharmaceutical company.	Servier Servier, founded in 1954, is the first independent pharmaceutical group.
Founding Date	Founding Date N/A	Founding Date 1986	Founding Date 1961	Founding Date 1958	Founding Date 1954
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Chicago, US HQ	Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US	Locations Mumbai, IN HQ	Locations HQ	Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more
Employees	Employees 7017% increase	Employees 26,015	Employees 5,4971% increase	Employees 4,8032% increase	Employees 12,9983% increase
Financial
Revenue (est.)	Revenue (est.) $20.2m (FY, 2020)	Revenue (est.) ₹333.8b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $9.3m (FY, 2020)	Cost of goods ₹134.9b (FY, 2026)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $10.8m (FY, 2020)	Gross profit ₹206.6b (FY, 2026)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($91.1m) (FY, 2020)	Net income ₹35b (FY, 2026)	Net income N/A	Net income N/A	Net income N/A